Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Yasuhiko Hirabayashi »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Yasuhide Kanayama < Yasuhiko Hirabayashi < Yasuhiko Hirami  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000168 (2010) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii ; Hideo HarigaeClinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice.
000666 (2013) Yasuhiko Hirabayashi [Japon] ; Tomonori IshiiThe DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.
000947 (2014) Ryu Watanabe [Japon] ; Yasuhiko Hirabayashi ; Hiroshi Okuno ; Tomonori Ishii ; Hideo HarigaeDramatic radiographic repair by tocilizumab in a very elderly patient with rheumatoid arthritis.
000956 (2014) Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiDrug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.
000957 (2014) Norihiro Nishimoto [Japon] ; Koichi Amano ; Yasuhiko Hirabayashi ; Takahiko Horiuchi ; Tomonori Ishii ; Mitsuhiro Iwahashi ; Masahiro Iwamoto ; Hitoshi Kohsaka ; Masakazu Kondo ; Tsukasa Matsubara ; Toshihide Mimura ; Hisaaki Miyahara ; Shuji Ohta ; Yukihiko Saeki ; Kazuyoshi Saito ; Hajime Sano ; Kiyoshi Takasugi ; Tsutomu Takeuchi ; Shigeto Tohma ; Tomomi Tsuru ; Yukitaka Ueki ; Jiro Yamana ; Jun Hashimoto ; Takaji Matsutani ; Miho Murakami ; Nobuhiro TakagiRetreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
000D73 (2015) Atsushi Ogata [Japon] ; Tatsuya Atsumi [Japon] ; Takaaki Fukuda [Japon] ; Yasuhiko Hirabayashi [Japon] ; Masaaki Inaba [Japon] ; Naoki Ishiguro [Japon] ; Motokazu Kai [Japon] ; Daisuke Kawabata [Japon] ; Daihei Kida [Japon] ; Hitoshi Kohsaka [Japon] ; Ryutaro Matsumura [Japon] ; Seiji Minota [Japon] ; Masaya Mukai [Japon] ; Takayuki Sumida [Japon] ; Kiyoshi Takasugi [Japon] ; Shigenori Tamaki [Japon] ; Tsutomu Takeuchi [Japon] ; Atsuhisa Ueda [Japon] ; Kazuhiko Yamamoto [Japon] ; Hisashi Yamanaka [Japon] ; Hajime Yoshifuji [Japon] ; Akira Nomura [Japon]Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.
001092 (2016) Yasuhiko Hirabayashi [Japon] ; Yasuhiko Munakata [Japon] ; Masayuki Miyata [Japon] ; Yukitomo Urata [Japon] ; Koichi Saito [Japon] ; Hiroshi Okuno [Japon] ; Masaaki Yoshida [Japon] ; Takao Kodera [Japon] ; Ryu Watanabe [Japon] ; Seiya Miyamoto [Japon] ; Tomonori Ishii [Japon] ; Shigeshi Nakazawa [Japon] ; Hiromitsu Takemori [Japon] ; Takanobu Ando [Japon] ; Takashi Kanno [Japon] ; Masataka Komagamine [Japon] ; Ichiro Kato [Japon] ; Yuichi Takahashi [Japon] ; Atsushi Komatsuda [Japon] ; Kojiro Endo [Japon] ; Chihiro Murai [Japon] ; Yuya Takakubo [Japon] ; Takao Miura [Japon] ; Yukio Sato [Japon] ; Kazunobu Ichikawa [Japon] ; Tsuneo Konta [Japon] ; Noriyuki Chiba [Japon] ; Tai Muryoi [Japon] ; Hiroko Kobayashi [Japon] ; Hiroshi Fujii [Japon] ; Yukio Sekiguchi [Japon] ; Akira Hatakeyama [Japon] ; Ken Ogura [Japon] ; Hirotake Sakuraba [Japon] ; Tomoyuki Asano [Japon] ; Hiroshi Kanazawa [Japon] ; Eiji Suzuki [Japon] ; Satoshi Takasaki [Japon] ; Kenichi Asakura [Japon] ; Kota Sugisaki [Japon] ; Yoko Suzuki [Japon] ; Michiaki Takagi [Japon] ; Takahiro Nakayama ; Hiroshi Watanabe [Japon] ; Keiki Miura [Japon] ; Yu Mori [Japon]Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group.
002C78 (2020) Yasuhiko Hirabayashi [Japon]Tocilizumab, an anti-interleukin-6 receptor antibody, efficiently ameliorates persistent joint inflammation in rheumatoid arthritis.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Yasuhiko Hirabayashi" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Yasuhiko Hirabayashi" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Yasuhiko Hirabayashi
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021